Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Progenics Pharmaceuticals Inc (NASDAQ:PGNX)

4.21
Delayed Data
As of Feb 05
 -0.08 / -1.86%
Today’s Change
3.74
Today|||52-Week Range
11.15
-31.32%
Year-to-Date
No recent news for Progenics Pharmaceuticals Inc.

Today’s Trading

Previous close4.29
Today’s open4.24
Day’s range4.14 - 4.37
Volume1,062,930
Average volume (3 months)997,743
Market cap$293.9M
Dividend yield--
Data as of 4:00pm ET, 02/05/2016

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-1,091.67%
Earnings growth (next 5 years)+7.00%
Revenue growth (last year)+464.45%
P/E ratioNM
Price/Sales11.63
Price/Book2.35

Competitors

 Today’s
change
Today’s
% change
XNPTXenoport Inc-0.42-8.27%
AKBAAkebia Therapeutics ...-0.27-3.50%
INFIInfinity Pharmaceuti...-0.26-4.35%
OMEDOncoMed Pharmaceutic...-0.20-2.10%
Data as of 4:14pm ET, 02/05/2016

Financials

Next reporting dateMarch 14, 2016
EPS forecast (this quarter)-$0.14
Annual revenue (last year)$44.4M
Annual profit (last year)$4.4M
Net profit margin9.94%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark Robert Baker
Chief Financial Officer &
Senior Vice President
Patrick Fabbio
Corporate headquarters
Tarrytown, New York

Forecasts

Partner Offers